Statistical flag only — not an accusation of fraud
This provider's $28.8M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 68% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 78/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $145.29 | $52.02 | 2.79x | $93.27 | $1.9M | 36.1K | 37 |
| 2015 | $153.87 | $57.74 | 2.66x | $96.13 | $2.4M | 41.1K | 38 |
| 2016 | $154.74 | $57.19 | 2.71x | $97.55 | $2.4M | 42.0K | 40 |
| 2017 | $159.79 | $56.77 | 2.81x | $103.02 | $2.5M | 43.8K | 41 |
| 2018 | $162.31 | $56.25 | 2.89x | $106.06 | $2.7M | 48.0K | 47 |
| 2019 | $165.57 | $56.28 | 2.94x | $109.29 | $2.7M | 47.9K | 38 |
| 2020 | $153.19 | $58.39 | 2.62x | $94.80 | $3.2M | 54.7K | 61 |
| 2021 | $106.28 | $44.34 | 2.40x | $61.94 | $4.0M | 90.2K | 108 |
| 2022 | $83.31 | $33.38 | 2.50x | $49.93 | $3.9M | 117.0K | 130 |
| 2023 | $49.68 | $19.32 | 2.57x | $30.36 | $3.2M | 163.3K | 155 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 189.6K | $9.6M | $50.64 | 3.34x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 26.0K | $2.1M | $81.16 | 1.62x |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | 29.2K | $2.1M | $70.91 | 2.39x |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 4.5K | $1.6M | $351.36 | 2.97x |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | 15.7K | $1.3M | $80.67 | 2.22x |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | 43.4K | $1.0M | $23.78 | 3.77x |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 2.9K | $909.8K | $314.50 | 2.33x |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | 3.8K | $807.0K | $215.03 | 2.14x |
| 88360 | Microscopic genetic analysis of tumor, manual | 7.9K | $792.8K | $100.07 | 2.15x |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | 16.0K | $792.0K | $49.55 | 3.71x |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 22.9K | $725.6K | $31.67 | 1.86x |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | 6.6K | $514.8K | $77.79 | 1.95x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 19.1K | $474.6K | $24.90 | 1.00x |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | 3.3K | $384.7K | $117.68 | 2.03x |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | 11.7K | $368.8K | $31.64 | 3.80x |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 8.7K | $345.1K | $39.78 | 1.78x |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | 5.3K | $312.0K | $58.57 | 1.88x |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | 2.2K | $299.5K | $138.34 | 1.95x |
| 80053 | Blood test, comprehensive group of blood chemicals | 20.6K | $213.6K | $10.36 | 2.03x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 5.1K | $201.9K | $39.40 | 1.75x |
This provider submits charges 2.66 times higher than what Medicare actually pays.
A markup ratio of 2.66x means for every $100 Medicare pays, this provider initially charges $266. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in WA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America | Seattle, WA | $203.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Seattle, WA | $97.9M | ⚠️ Flagged |
| Carenexa, Llc | Vancouver, WA | $70.5M | ✓ Clear |
| Adaptive Biotechnologies Corporation | Seattle, WA | $54.5M | ✓ Clear |
| Regional Toxicology Services, Llc | Tacoma, WA | $37.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data